Serial direct sodium removal in patients with heart failure and diuretic resistance

被引:2
|
作者
Rao, Veena S. [1 ,11 ]
Ivey-Miranda, Juan B. [1 ,2 ]
Cox, Zachary L. [3 ,4 ]
Moreno-Villagomez, Julieta [1 ,5 ]
Ramos-Mastache, Daniela [5 ]
Neville, Daniel [1 ]
Balkcom, Natasha [1 ]
Asher, Jennifer L. [6 ]
Bellumkonda, Lavanya [1 ]
Bigvava, Tamar [7 ]
Shaburishvili, Tamaz [7 ]
Bartunek, Jozef [8 ]
Wilson, F. Perry [9 ,10 ]
Finkelstein, Fredrick [9 ]
Maulion, Christopher [1 ]
Turner, Jeffrey M. [9 ]
Testani, Jeffrey M. [1 ,11 ]
机构
[1] Yale Univ, Sch Med, Dept Internal Med, Sect Cardiovasc Med, New Haven, CT 06510 USA
[2] Inst Mexicano Seguro Social, Hosp Cardiol, Mexico City, Mexico
[3] Lipscomb Univ, Dept Pharm Practice, Coll Pharm, Nashville, TN USA
[4] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN USA
[5] Univ Nacl Autonoma Mexico, Fac Estudios Super Iztacala, Mexico City, Mexico
[6] Yale Univ, Sch Med, Dept Med, Div Comparat Med, New Haven, CT USA
[7] Tbilisi Heart & Vasc Clin, 18-20 Ljubljana St, Tbilisi 0159, Georgia
[8] Onze Lieve Vrouw Hosp, Cardiovasc Ctr, Aalst, Belgium
[9] Yale Univ, Sch Med, Dept Med, Div Nephrol, New Haven, CT USA
[10] Yale Univ, Sch Med, Clin & Translat Res Accelerator, New Haven, CT USA
[11] Yale Univ, 135 Coll St,Suite 230, New Haven, CT 06510 USA
关键词
Cardiorenal syndrome; Diuretic; Heart failure; Sodium; SALT INTAKE; PATHOPHYSIOLOGY; ULTRAFILTRATION; STRATEGIES; INSIGHTS; THERAPY; BALANCE; STORAGE; KIDNEY;
D O I
10.1002/ejhf.3196
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims Loop diuretics may exacerbate cardiorenal syndrome (CRS) in heart failure (HF). Direct sodium removal (DSR) using the peritoneal membrane, in conjunction with complete diuretic withdrawal, may improve CRS and diuretic resistance. Methods and results Patients with HF requiring high-dose loop diuretics were enrolled in two prospective, single-arm studies: RED DESERT (n = 8 euvolaemic patients), and SAHARA (n = 10 hypervolaemic patients). Loop diuretics were withdrawn, and serial DSR was utilized to achieve and maintain euvolaemia. At baseline, participants required a median 240 mg (interquartile range [IQR] 200-400) oral furosemide equivalents/day, which was withdrawn in all participants during DSR (median time of DSR 4 weeks [IQR 4-6]). Diuretic response (queried by formal 40 mg intravenous furosemide challenge and 6 h urine sodium quantification) increased substantially from baseline (81 +/- 37 mmol) to end of DSR (223 +/- 71 mmol, p < 0.001). Median time to re-initiate diuretics was 87 days, and the median re-initiation dose was 8% (IQR 6-10%) of baseline. At 1 year, diuretic dose remained substantially below baseline (30 [IQR 7.5-40] mg furosemide equivalents/day). Multiple dimensions of kidney function such as filtration, uraemic toxin excretion, kidney injury, and electrolyte handling improved (p < 0.05 for all). HF-related biomarkers including N-terminal pro-B-type natriuretic peptide, carbohydrate antigen-125, soluble ST2, interleukin-6, and growth differentiation factor-15 (p < 0.003 for all) also improved. Conclusions In patients with HF and diuretic resistance, serial DSR therapy with loop diuretic withdrawal was feasible and associated with substantial and persistent improvement in diuretic resistance and several cardiorenal parameters. If replicated in randomized controlled studies, DSR may represent a novel therapy for diuretic resistance and CRS. Clinical Trial Registration: RED DESERT (NCT04116034), SAHARA (NCT04882358). [GRAPHICS] .
引用
收藏
页码:1215 / 1230
页数:16
相关论文
共 50 条
  • [21] Ultrafiltration therapy in patients with severe heart failure and resistance to diuretic treatments
    Di Gesaro, G. Gabriele
    Levantino, P.
    Agnese, V.
    Falletta, C.
    Mina, C.
    Romano, G.
    Scardulla, C.
    Clemenza, F.
    EUROPEAN JOURNAL OF HEART FAILURE, 2015, 17 : 72 - 73
  • [22] How to predict diuretic resistance in acutely decompensated heart failure patients
    Francisco Gama, F.
    Felix Oliveira, A.
    Freitas, P.
    Tralhao, A.
    Ferreira, J.
    Araujo, I.
    Marques, F.
    Fonseca, C.
    EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 : 262 - 263
  • [23] Effects of Glucocorticoids in Potentiating Diuresis in Heart Failure Patients With Diuretic Resistance
    Liu, Chao
    Liu, Kunshen
    JOURNAL OF CARDIAC FAILURE, 2014, 20 (09) : 625 - 629
  • [24] Markers of diuretic resistance in emergency department patients with acute heart failure
    Doering A.
    Jenkins C.A.
    Storrow A.B.
    Lindenfeld J.A.
    Fermann G.J.
    Miller K.F.
    Sperling M.
    Collins S.P.
    International Journal of Emergency Medicine, 2017, 10 (1)
  • [25] Factors predicting diuretic resistance in patients with acute decompensated heart failure
    Pratama, A. P.
    Hersunarti, N.
    Soerarso, R.
    Zahara, R.
    Kurniawati, Y.
    Hasanah, D. Y.
    Sukmawan, R.
    EUROPEAN HEART JOURNAL, 2022, 43 : 874 - 874
  • [26] Diuretic resistance in patients with chronic heart failure: mechanisms, prevention, and treatment
    Kalyuzhin, V. V.
    Teplyakov, A. T.
    Bespalova, I. D.
    Kalyuzhina, E., V
    Terentyeva, N. N.
    Livshits, I. K.
    Ostanko, V. L.
    Grakova, E., V
    Kopeva, K., V
    Usov, V. Yu
    Garganeeva, N. P.
    Gorelova, Yu, V
    BYULLETEN SIBIRSKOY MEDITSINY, 2022, 21 (02): : 152 - 167
  • [27] Diuretic resistance in a population of acutely decompensated chronic heart failure patients
    Sharka, I. Ilir
    Myftiu, S.
    Quka, A.
    Rustemaj, J.
    Duka, A.
    Kristo, A.
    Balla, I.
    EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 : 544 - 544
  • [28] Decompensated heart failure and diuretic resistance - Reply
    Costanzo, Maria Rosa
    Sobotka, Paul A.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 48 (05) : 1060 - 1060
  • [29] Diuretic therapy and resistance in congestive heart failure
    Ellison, DH
    CARDIOLOGY, 2001, 96 (3-4) : 132 - 143
  • [30] Prevalence and outcome of diuretic resistance in heart failure
    Trullas, Joan-Carles
    Casado, Jesus
    Morales-Rull, Jose-Luis
    Formiga, Francesc
    Conde-Martel, Alicia
    Quiros, Raul
    Epelde, Francisco
    Gonzalez-Franco, Alvaro
    Manzano, Luis
    Montero-Perez-Barquero, Manuel
    INTERNAL AND EMERGENCY MEDICINE, 2019, 14 (04) : 529 - 537